It is not insulin and is not an injectable diabetes medicine
Incorrect peptide content means actual dosing may be much higher or lower than intended, which directly affects both efficacy and side effect risk
When a patient's blood sugar levels are high, GLP-1 drugs send signals to their pancreas to secrete more insulin but the hormone-mimicking doesn't stop there
5 Conclusions and outlook Conventional HDACi is associated with drug resistance, toxicity, and limited efficacy in clinical applications, making the development of novel HDACi an urgent issue
Sloan SA, Andersen J, Paca AM, Birey F, Paca SP
Conclusion BPC-157 is a regenerative-focused peptide studied for its potential to support tissue repair, recovery, and overall physical resilience